Results 101 to 110 of about 15,754,334 (318)

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

The weak solutions of a doubly nonlinear parabolic equation related to the p(x) $p(x)$-Laplacian

open access: yesAdvances in Difference Equations, 2019
A nonlinear degenerate parabolic equation related to the p(x) $p(x)$-Laplacian ut=div(b(x)|∇a(u)|p(x)−2∇a(u))+∑i=1N∂bi(u)∂xi+c(x,t)−b0a(u) $$ {u_{t}}= \operatorname{div} \bigl({b(x)} { \bigl\vert {\nabla a(u)} \bigr\vert ^{p(x) - 2}}\nabla a(u) \bigr ...
Huashui Zhan
doaj   +1 more source

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma

open access: yesMolecular Oncology, EarlyView.
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken   +7 more
wiley   +1 more source

Nghi��n c���u s��� h��nh th��nh xo��y ph��n c���c c���a v���t li���u PbTiO3 ��� k��ch th�����c nanomet.pdf

open access: yes, 2022
V t li u s t i n PbTiO3 ang tr th nh trung t m c a nhi u thi t b c ng ngh ti n ti n, v d nh b nh truy c p ng u nhi n (FeRAM), c m bi n (sensor), b d n ng (actuator) v c c b chuy n i (transducers) trong c c h vi c i n t (MEMS/NEMS).
openaire   +1 more source

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

open access: yesMolecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix   +13 more
wiley   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

open access: yesMolecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li   +10 more
wiley   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

open access: yesMolecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung   +17 more
wiley   +1 more source

Redox regulation meets metabolism: targeting PRDX2 to prevent hepatocellular carcinoma

open access: yesMolecular Oncology, EarlyView.
PRDX2 acts as a central redox hub linking metabolic dysfunction‐associated steatohepatitis (MASH) to hepatocellular carcinoma (HCC). In normal hepatocytes, PRDX2 maintains redox balance and metabolic homeostasis under oxidative stress. In contrast, during malignant transformation, PRDX2 promotes oncogenic signaling, stemness, and tumor initiation ...
Naroa Goikoetxea‐Usandizaga   +2 more
wiley   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

open access: yesMolecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang   +3 more
wiley   +1 more source

Aptitud para riego del agua subterránea basada en la salinidad y sodicidad en las perforaciones realizadas entre 2004 y 2010 en los Oasis Norte y Centro de Mendoza

open access: yesRevista de la Facultad de Ciencias Agrarias, 2022
En Mendoza la actividad agrícola se concentra en oasis productivos que dependen exclusivamente del riego, donde aproximadamente un 70% de las propiedades utilizan agua subterránea.
Adriana Bermejillo   +7 more
doaj  

Home - About - Disclaimer - Privacy